NDC 0409-3294-61 - Potassium Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-3294
- Requested NDC
- 0409-3294-61
- Package NDCs from labels
- 0409-3294-15, 0409-3294-25, 0409-3294-61, 0409-3294-51
- Manufacturer
- Hospira, Inc. | Pfizer Healthcare India Private Limited
- Effective date
- 2026-04-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Potassium Acetate - Hospira, Inc. | Pfizer Healthcare India Private Limited | Hospira, Inc. | Pfizer Healthcare India Private Limited | 2026-04-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Potassium Acetate - Hospira, Inc. | Pfizer Healthcare India Private Limited | Hospira, Inc. | Pfizer Healthcare India Private Limited | 2026-04-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-3294-15 | Potassium Acetate | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, SOLUTION, CONCENTRATE | 50 | 10 | |
| 0409-3294-25 | Potassium Acetate | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 10 | |
| 0409-3294-51 | Potassium Acetate | 25 in 1 TRAY | INJECTION, SOLUTION, CONCENTRATE | 25 | 8 | |
| 0409-3294-61 | Potassium Acetate | 50 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, SOLUTION, CONCENTRATE | 50 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0409-3294 | POTASSIUM ACETATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 9 | Current NDC, Legacy NDC, 2 package rows | 20241113_c58f8112-d587-493a-91b7-2b48c80bb7bf.zip |
| 0409-3294 | POTASSIUM ACETATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 7 | Current NDC, Legacy NDC, 2 package rows | 20241116_e9772b82-1e2b-4c4b-aa47-677491dbf73c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-3294-15 | ML - Milliliter | 0409-3294 | 86e190fd-42a6-43f0-b633-3dc1ef6774ec | 1 | 2018-02-20 |
| 0409-3294-25 | ML - Milliliter | 0409-3294 | 53854f64-8b1e-4d81-bf61-2844946fe341 | 1 | 2014-07-02 |
| 0409-3294-51 | ML - Milliliter | 0409-3294 | 64cf7e99-ccdf-4383-b105-9f69445d4645 | 1 | 2012-07-24 |
| 0409-3294-61 | ML - Milliliter | 0409-3294 | 1a74aa9d-2921-44c2-b4dd-ea38bced3fd5 | 1 | 2018-02-20 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| POTASSIUM ACETATE | ACTIVE INGREDIENT | M911911U02 | POTASSIUM ACETATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 1 | |
| POTASSIUM ACETATE | ACTIVE INGREDIENT | M911911U02 | POTASSIUM ACETATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | POTASSIUM ACETATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | POTASSIUM ACETATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 1 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | POTASSIUM ACETATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 1 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | POTASSIUM ACETATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | POTASSIUM ACETATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | POTASSIUM ACETATE INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| SKIN TAG REMOVER | SALICYLIC ACID | Shenzhen Yaozhihong Technology Co., Ltd. | 4246d4d5-9955-ba5a-e063-6394a90a8448 | 2025-10-29 | Warnings | Q40Q9N063P |
| Sterile Water | WATER | ICU Medical Inc. | 1c0bbcb7-5ed6-4ee7-b297-080d3359474e | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2025-10-27 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| NORMOSOL-M AND DEXTROSE | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM ACETATE, AND MAGNESIUM ACETATE | ICU Medical Inc. | aba60c84-94d9-46d0-bdbb-25e0c4e8cc41 | 2025-10-24 | Warnings, Adverse reactions | M911911U02 |
| Sterile Water | WATER | Becton Dickinson and Company | cab03cda-4660-4020-a3be-bf86242ff664 | 2025-10-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Xpect Eyewash | EYEWASH | Cintas Corporation | 1d69365d-662b-4248-8fa9-1629451b549a | 2025-09-30 | Warnings | 059QF0KO0R |
| CheBoho TEA TREE ACNE | CHEBOHO TEA TREE ACNE | Opalshi(Guangzhou)E-commerce Co. Ltd. | 3fc4cf84-b2da-c593-e063-6394a90abc5c | 2025-09-27 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | ProPharma Distribution | 3f2ae880-852f-b45d-e063-6394a90aa1cc | 2025-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.